AzTrials
AzTrials

Thoracic SympathectomyNCT04486014

Analgesic Effect of Erector Spinae Versus Serratus Anterior Plane Block for Thoracoscopic Sympathectomy

A study testing Erector spinae plane block and Serratus anterior plane block in people with Thoracic Sympathectomy, run by Mansoura University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Thoracic incisions are painful and associated with chronic post-surgical pain and inadequate analgesia is associated with poorer postoperative outcomes. Recent progress has been made in the field of thoracic anesthesia by improving analgesic modalities such as PECS 1 and PECS 2, intercostal plane block, paravertebral… Read more about this study

Who is it for?
Ages 21 to 40 years
Conditions the study is for
Thoracic Sympathectomy
What is being tested?
Erector spinae plane block and Serratus anterior plane block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
110 participants
Where
1 siteEgypt
Study dates
14 Sep 2020to Jan 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 40 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • American Society of Anesthesiologists grade I or II physical status

Who cannot join

  • Patients who had coagulopathies
  • local infections
  • neuropathies
  • neuromuscular disease
  • psychiatric disease
  • history of thoracic surgery
Show all 9Show fewer
  • history of allergy to local anesthetics.
  • receiving chronic analgesic therapy
  • drug abusers

Trial locations and contacts

1 site in 1 country.

Mohamed Y Makharita, MD contact

00201284122800

m_younis24@yahoo.com

Doaa G Diab, MD contact

00201069507088

basmalg@yahoo.com

Egypt1 site, 1 recruiting
  • Mansoura University

    Al Mansurah, DK, 050

    Mohamed Y Makharita, MD, 00201284122800, m_younis24@yahoo.com

    Doaa G Diab, MD, 00201069507088, basmalg@yahoo.com

    Recruiting

Other trials in Egypt

About this study

Official title: A Comparative Study of the Analgesic Effect of Ultrasound-guided Erector Spinae Plane Block Versus Serratus Anterior Plane Block for Thoracoscopic Sympathectomy Surgeries

  • Thoracic incisions are painful and associated with chronic post-surgical pain and inadequate analgesia is associated with poorer postoperative outcomes. Recent progress has been made in the field of thoracic anesthesia by improving analgesic modalities such as PECS 1 and PECS 2, intercostal plane block, paravertebral regional anesthesia, ultrasound-guided erector spinae and serratus anterior plane block.
  • Administered of the local anesthetic in erector spinae plane block is in the interfascial plane between the transverse process of the vertebra and the erector spinae muscles, spreading to multiple paravertebral spaces. It affects both the ventral and dorsal rami and leading to blockage of both visceral and somatic pain.
  • Ultrasound-guided serratus anterior plane block is a facial plane block that provides analgesia by blocking of lateral branches of intercostal nerves above or below the serratus plane muscle.
  • We hypothesize that the ultrasound-guided erector spinae plane block may have better quality than the serratus anterior plane block for patients undergoing thoracoscopic sympathectomy as erector spinea plane blocks visceral and somatic pain.
Read the detailed description

Primary palmar hyperhidrosis (PPH) refers to the excessive secretion of exocrine glands on the palms, which is often accompanied by the head, face, or plantar hyperhidrosis. PPH demonstrates no obvious organic cause; however, some patients may feel distressed because their palms sweat more than normal, and such a situation may lead to severe psychological, social, and occupational dysfunction.

Endoscopic thoracic sympathectomy abolishes eccrine sweating in all areas supplied by the postganglionic fibers with its complications which include post-sympathetic neuralgia which is the most important, wound infection, hemorrhage, pneumothorax, horner syndrome, no response to the operation and compensatory hyperhidrosis in non-denervated areas.

Forero described ultrasound-guided erector spinae plane block for treatment of thoracic neuropathic pain and explained it as a peri-paravertebral regional anesthesia technique that has been used for prevention of postoperative pain in various surgeries.

Ultrasound-guided serratus anterior plane block is a facial plane block which provides analgesia by blocking of lateral branches of intercostal nerves above or below the serratus plane muscle. There are few cases and studies in the literature reporting successful analgesia provided by serratus anterior plane block

Being tested
Erector spinae plane block, Serratus anterior plane block

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Erector spinae plane blockProcedure or surgery

    Erector Spinae Group (Group E) will receive bilateral ultrasound-guided erector spinae plane block using 30 ml hyperbaric bupivacaine 0.25% will be injected between erector spinae muscle and transverse process of T4

  • Serratus anterior plane blockProcedure or surgery

    Serratus anterior Group (Group S) will undergo bilateral ultrasound-guided serratus anterior plane block with 30 ml hyperbaric bupivacaine 0.25% will be injected above or below serratus anterior muscle at the level of 4th and 5th rib on the midaxillary line

Study groups in NCT04486014
Study groupRoleWhat they receive
Erector spinae plane block (ESP)ExperimentalPatients would receive erector spinae plane block
Receives: Procedure: Erector spinae plane block
Serratus anterior plane block (SAP)ExperimentalPatients would receive serratus anterior plane block
Receives: Procedure: Serratus anterior plane block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The total analgesic consumption

    cumulative consumption of opioids during the first postoperative day

    Measured: 1st 24 hours after surgery

Secondary outcomes (13)
  1. Postoperative severity of the pain

    Visual analogue scale (0-100),where 0 point is equal to no pain and 100 indicate the worst possible pain

    Measured: every 2 hours for 12hours and then at 16, 20 and 24 hours postoperatively

  2. The total amount of fentanyl consumption

    cumulative consumption of fentanyl during the first postoperative day

    Measured: 1st 24 hours after surgery

  3. The total amount of paracetamol consumption

    cumulative consumption of paracetamol during the first post operative day

    Measured: 1st 24 hours after surgery

  4. Duration of analgesia

    from the end of block till the time for the first analgesic requirement (ketorolac)

    Measured: within 24 hours after surgery

  5. Nausea

    number of patients with nausea

    Measured: 1st 24 hours after surgery

  6. Vomiting

    number of patients with vomiting

    Measured: 1st 24 hours after surgery

  7. Patient Satisfaction

    evaluated as 5:excellent, 4:very good, 3:good, 2: fair, 1:poor

    Measured: After 12 and 24 hours after surgery

  8. Heart rate

    changes in heart rate

    Measured: Intraoperative (every 10 minutes till the end of surgery)

  9. Peripheral oxygen saturation

    changes in Peripheral oxygen saturation as measured with pulse oximetry

    Measured: Intraoperative (every 10 minutes till the end of surgery)

  10. End-tidal carbon dioxide tension

    changes in end-tidal carbon dioxide tension as measured with capnography

    Measured: Intraoperative (every 10 minutes till the end of surgery)

  11. systolic blood pressure

    changes in systolic blood pressure

    Measured: Intraoperative (every 10 minutes till the end of surgery)

  12. diastolic blood pressures

    changes in diastolic blood pressure

    Measured: Intraoperative (every 10 minutes till the end of surgery)

  13. mean blood pressures

    changes in mean arterial blood pressure

    Measured: Intraoperative (every 10 minutes till the end of surgery)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jul 2020
  2. Study start14 Sep 2020
  3. Primary completionJul 2021 (estimated)
  4. Study completionJan 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
110 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04486014
Sponsor's protocol ID
MD.20.04.307
Status last verified
Sep 2020
First submitted
22 Jul 2020
Last updated
8 Feb 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) Clinical Study Report (CSR)

Questions about this trial

What is this clinical trial studying?

A study testing Erector spinae plane block and Serratus anterior plane block in people with Thoracic Sympathectomy, run by Mansoura University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mohamed Y Makharita, MD (00201284122800, m_younis24@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The total analgesic consumption (time frame: 1st 24 hours after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Feb 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in